MedPath

Comparison of the Therapeutic Effects of Intra-Articular Injection of Ozone and Corticosteroid in Knee Osteoarthritis

Not Applicable
Completed
Conditions
Knee Osteoarthritis
Interventions
Other: Ozone - oxygen Therapy
Other: Corticosteroid
Registration Number
NCT06328270
Lead Sponsor
Sisli Hamidiye Etfal Training and Research Hospital
Brief Summary

This clinical trial aimed to involve patients aged 40-85 years who had been experiencing knee pain for at least 6 months and had received a clinical diagnosis of knee osteoarthritis through radiologic imaging. The patients were randomly assigned to two groups. One group received a 3-week intra-articular injection of 15 mg/ml ozone, while the second group received a 1 ml intra-articular injection of betamethasone. All patients were evaluated before treatment, as well as 4 and 12 weeks after the first dose of treatment. The study evaluated treatment efficacy using the Visual Pain Score (VAS) and the Western Ontario and McMaster Universities Arthritis Index (WOMAC).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • 40-85 years old,
  • have experienced knee pain and/or limited joint range of motion for at least 6 months,
  • have a diagnosis of KOA supported by radiographic imaging.
Exclusion Criteria
  • patients had undergone knee joint surgery,
  • had a history of previous intra-articular injections,
  • had any rheumatological disease or malignancy,
  • being pregnant,
  • had pain radiating to the knee and leg.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Study GroupOzone - oxygen TherapyThe group received a 3-week intra-articular injection of 15 mg/ml ozone.
Control GroupCorticosteroidThe group received a 1 ml intra-articular injection of betamethasone
Primary Outcome Measures
NameTimeMethod
Visual Pain Score4 weeks after the first dose of treatment

Pain status of the patients was questioned with a scale between 0-10

Western Ontario and McMaster Universities Arthritis Index4 weeks after the first dose of treatment

The Western Ontario and McMaster Universities Arthritis Index (WOMAC) is widely used in the evaluation of Hip and Knee Osteoarthritis. It is a self-administered questionnaire consisting of 24 items divided into 3 subscales:\[1\] Pain (5 items): during walking, using stairs, in bed, sitting or lying, and standing upright Stiffness (2 items): after first waking and later in the day Physical Function (17 items): using stairs, rising from sitting, standing, bending, walking, getting in / out of a car, shopping, putting on / taking off socks, rising from bed, lying in bed, getting in / out of bath, sitting, getting on / off toilet, heavy domestic duties, light domestic duties

Secondary Outcome Measures
NameTimeMethod
Western Ontario and McMaster Universities Arthritis Index12 weeks after the first dose of treatment

The Western Ontario and McMaster Universities Arthritis Index (WOMAC) is widely used in the evaluation of Hip and Knee Osteoarthritis. It is a self-administered questionnaire consisting of 24 items divided into 3 subscales:\[1\] Pain (5 items): during walking, using stairs, in bed, sitting or lying, and standing upright Stiffness (2 items): after first waking and later in the day Physical Function (17 items): using stairs, rising from sitting, standing, bending, walking, getting in / out of a car, shopping, putting on / taking off socks, rising from bed, lying in bed, getting in / out of bath, sitting, getting on / off toilet, heavy domestic duties, light domestic duties

Visual Pain Score12 weeks after the first dose of treatment

Pain status of the patients was questioned with a scale between 0-10

Trial Locations

Locations (1)

University of Health Sciences, Şişli Hamidiye Etfal Training and Research Hospital

🇹🇷

Istanbul, Turkey

© Copyright 2025. All Rights Reserved by MedPath